Antianxiety behavior associated with the brain-derived neurotrophic factor-mammalian target of rapamycin signaling pathway was revealed by knockdown of HCN1 channels in the hippocampal dorsal CA1 region, suggesting that HCN1 protein might be a target for anxiety disorder treatment (14). The gene discussed is MTOR; the disease is anxiety disorder.